These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
208 related items for PubMed ID: 11705253
1. The combination formulation of clindamycin 1% plus benzoyl peroxide 5% versus 3 different formulations of topical clindamycin alone in the reduction of Propionibacterium acnes. An in vivo comparative study. Leyden J, Kaidbey K, Levy SF. Am J Clin Dermatol; 2001; 2(4):263-6. PubMed ID: 11705253 [Abstract] [Full Text] [Related]
2. Effect of topical benzoyl peroxide/clindamycin versus topical clindamycin and vehicle in the reduction of Propionibacterium acnes. Leyden JJ. Cutis; 2002 Jun; 69(6):475-80. PubMed ID: 12078851 [Abstract] [Full Text] [Related]
3. Comparative efficacy of clindamycin and benzoyl peroxide for in vivo suppression of Propionibacterium acnes. Gans EH, Kligman AM. J Dermatolog Treat; 2002 Sep; 13(3):107-10. PubMed ID: 12227872 [Abstract] [Full Text] [Related]
4. A randomized, double-blind comparison of a clindamycin phosphate/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris. Cunliffe WJ, Holland KT, Bojar R, Levy SF. Clin Ther; 2002 Jul; 24(7):1117-33. PubMed ID: 12182256 [Abstract] [Full Text] [Related]
5. The development of antibiotic resistance in Propionibacterium acnes. Leyden J, Levy S. Cutis; 2001 Feb; 67(2 Suppl):21-4. PubMed ID: 11236211 [Abstract] [Full Text] [Related]
6. Antibiotic-resistant Propionibacterium acnes suppressed by a benzoyl peroxide cleanser 6%. Leyden JJ, Wortzman M, Baldwin EK. Cutis; 2008 Dec; 82(6):417-21. PubMed ID: 19181031 [Abstract] [Full Text] [Related]
7. Cutibacterium acnes persists despite topical clindamycin and benzoyl peroxide. Heckmann N, Heidari KS, Jalali O, Weber AE, She R, Omid R, Vangsness CT, Rick Hatch GF. J Shoulder Elbow Surg; 2019 Dec; 28(12):2279-2283. PubMed ID: 31471244 [Abstract] [Full Text] [Related]
8. Clindamycin/benzoyl peroxide gel: a review of its use in the management of acne. Warner GT, Plosker GL. Am J Clin Dermatol; 2002 Dec; 3(5):349-60. PubMed ID: 12069641 [Abstract] [Full Text] [Related]
9. Community-based trial results of combination clindamycin 1%--benzoyl peroxide 5% topical gel plus tretinoin microsphere gel 0.04% or 0.1% or adapalene gel 0.1% in the treatment of moderate to severe acne. Kircik L. Cutis; 2007 Jul; 80(1 Suppl):10-4. PubMed ID: 17824581 [Abstract] [Full Text] [Related]
10. The effects of acne treatment with a combination of benzoyl peroxide and erythromycin on skin carriage of erythromycin-resistant propionibacteria. Eady EA, Bojar RA, Jones CE, Cove JH, Holland KT, Cunliffe WJ. Br J Dermatol; 1996 Jan; 134(1):107-13. PubMed ID: 8745894 [Abstract] [Full Text] [Related]
11. In vivo antibacterial effects of tretinoin-clindamycin and clindamycin alone on Propionibacterium acnes with varying clindamycin minimum inhibitory. Leyden JJ. J Drugs Dermatol; 2012 Dec; 11(12):1434-8. PubMed ID: 23377513 [Abstract] [Full Text] [Related]
12. In-vivo Effectiveness of Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel on Antibiotic-sensitive and Resistant Propionibacterium acnes. Leyden JJ, Preston N, Osborn C, Gottschalk RW. J Clin Aesthet Dermatol; 2011 May; 4(5):22-6. PubMed ID: 21607190 [Abstract] [Full Text] [Related]
14. [Bacterial resistance in acne? A meta-analysis of the controversy]. Alvarez-Sánchez M, Rodríguez-Ayala E, Ponce-Olivera RM, Tirado-Sánchez A, Arellano-Mendoza MI. Cir Cir; 2016 Jul; 84(3):190-5. PubMed ID: 26738649 [Abstract] [Full Text] [Related]
15. Efficacy and Safety of VB-1953 Topical Gel in Non-Responder Acne Patients with Clindamycin-Resistant Cutibacterium acnes. Batra R, Sadhasivam S, Saini S, Gupta S, Bisen RKS, Sinha M, Ghosh S, Jain S. Drugs R D; 2020 Jun; 20(2):95-104. PubMed ID: 32222937 [Abstract] [Full Text] [Related]
16. Antibiotic resistance in the topical treatment of acne vulgaris. Leyden JJ. Cutis; 2004 Jun; 73(6 Suppl):6-10. PubMed ID: 15228128 [Abstract] [Full Text] [Related]
17. Comparison of 2 clindamycin 1%-benzoyl peroxide 5% topical gels used once daily in the management of acne vulgaris. Dhawan SS. Cutis; 2009 May; 83(5):265-72. PubMed ID: 19537284 [Abstract] [Full Text] [Related]
18. Comparison of the efficacy and safety of a combination topical gel formulation of benzoyl peroxide and clindamycin with benzoyl peroxide, clindamycin and vehicle gel in the treatments of acne vulgaris. Leyden JJ, Berger RS, Dunlap FE, Ellis CN, Connolly MA, Levy SF. Am J Clin Dermatol; 2001 May; 2(1):33-9. PubMed ID: 11702619 [Abstract] [Full Text] [Related]
19. The efficacy and safety of a combination benzoyl peroxide/clindamycin topical gel compared with benzoyl peroxide alone and a benzoyl peroxide/erythromycin combination product. Leyden JJ, Hickman JG, Jarratt MT, Stewart DM, Levy SF. J Cutan Med Surg; 2001 May; 5(1):37-42. PubMed ID: 11281433 [Abstract] [Full Text] [Related]
20. Benzoyl peroxide-based combination therapies for acne vulgaris: a comparative review. Taylor GA, Shalita AR. Am J Clin Dermatol; 2004 May; 5(4):261-5. PubMed ID: 15301572 [Abstract] [Full Text] [Related] Page: [Next] [New Search]